NCT00002006View on ClinicalTrials.gov

A Phase I/II Pilot Study of Simultaneously Administered Rhu GM-CSF ( CHO Cell ) and Azidothymidine ( AZT ) in Patients With Severe HIV Infection and Leukopenia: Pharmacokinetics and Feasibility

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV InfectionsCytopenias
Interventions
DRUG

Zidovudine

DRUG

Sargramostim

Trial Locations (1)

20892

Natl Cancer Institute, Bethesda

Sponsors

Lead Sponsor

Sandoz
All Listed Sponsors
lead

Sandoz

INDUSTRY

NCT00002006 - A Phase I/II Pilot Study of Simultaneously Administered Rhu GM-CSF ( CHO Cell ) and Azidothymidine ( AZT ) in Patients With Severe HIV Infection and Leukopenia: Pharmacokinetics and Feasibility | Biotech Hunter | Biotech Hunter